학술논문
Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective
Document Type
Article
Author
Source
In: Gynecologic Oncology . (Gynecologic Oncology, October 2022, 167(1):115-122)
Subject
Language
English
ISSN
10956859
00908258
00908258